Authors’ Reply to Comment on “Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome”
Crossref DOI link: https://doi.org/10.1007/s40273-021-01006-9
Published Online: 2021-03-06
Published Print: 2021-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Neuberger, Edward E. https://orcid.org/0000-0003-4037-0295
Carlson, Josh J.
Veenstra, David L.
Text and Data Mining valid from 2021-03-06
Version of Record valid from 2021-03-06
Article History
Accepted: 6 February 2021
First Online: 6 March 2021